2021, Number 3
<< Back Next >>
Rev Hematol Mex 2021; 22 (3)
Aliis vivere: 25 years of private Hematology practice
Sánchez-Guerrero SA
Language: Spanish
References: 13
Page: 143-154
PDF size: 252.40 Kb.
ABSTRACT
Background: I thought my private practice was useless for research and teaching
purposes. What a bias!
Objective: To review the records of patients seen the last 25 years to know what
hematologic diseases I have seen assessing them from the medical, social and ethical
perspectives.
Materials and Methods: A retrospective analysis of clinical charts focusing on:
patients’ age and gender, diagnosis, lab testing and therapies. There were three main
disease categories: anemia, coagulopathy and neoplasia.
Results: There were included 664 records. Sixty percent of patients were females.
Forty-six percent had anemia, 26% had coagulopathy, 16% had neoplasia and 12%
came for non-hematologic diseases. The most common anemia was microcytic-hypochromic
followed by the normocytic-normochromic anemia and, lastly, macrocytic.
Regarding coagulopathies, the main cause was autoimmune thrombocytopenia followed
by inherited thrombosis and hemorrhagic diathesis. In terms of neoplasms, the most
frequently seen were: lymphomas, myelodisplasia, chronic lymphocytic leukemia and
multiple myeloma. This latter disease category included the eldest population as well
as those patients most commonly seeking attention in public hospitals.
Conclusions: Iron-deficiency anemia is a health problem even among wealthy
people. Hematologic malignancies are not the most common cause of consultation
for the general hematologist and many patients cannot afford the high costs of antineoplastic
therapies.
REFERENCES
Jaime-Pérez JC, Treviño-Reyna G, Aguilar-Calderón P, Cantú- Rodríguez OG, et al. Contributions of a regional approach to document hematologic diseases in Mexico: a 10-year experience in an open population. Hematology 2018; 23: 803-9. doi: 10.1080/10245332.2018.1498166.
López-García YK, Colunga-Pedraza PR, Tarín-Arzaga L, López-Garza MI, et al. Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care. Hematology 2018; 23: 658-63. doi: 10.1080/10245332.2018.1461290.
Gómez-Almaguer D, Marcos-Ramírez ER, Montaño- Figueroa EH, Ruiz-Argüelles GJ, et al. Acute leukemia characteristics are different around the world: the Mexican perspective. Clin Lymphoma Myeloma Leuk 2017; 17: 46- 51. doi: 10.1016/j.clml.2016.09.003.
Gutiérrez JP, Rivera-Donmarco J, Shamah-Levy T, et al. Encuesta nacional de salud y nutrición 2012. Resultados nacionales. Cuernavaca. Instituto Nacional de Salud Pública. 2012.
Borja-Aburto VH, Dávila-Torres J, Rascón-Pacheco RA, González-León, M, et al. Cancer mortality in the Mexican Social Security Institute: 1989-2013. Salud Pública Méx 2016; 58: 153-61.
Tay-Teo K, Ilbawi A, Hill SR. Comparison of sales income and research and development costs for FDA-approved cancer drugs sold by originator drug companies. JAMA 2019; 2 (1): 186875. doi: 10.1001/jamanetworkopen.2018.6875.
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-3. https://doi.org/10.1038/s41586- 020-2012-7.
Porter R. The greatest benefit to mankind. 1st ed. New York: WW Norton & Co., 1997.
Hipócrates. Tratados. Madrid: Ed. Gredos, 2015.
Virgilio. Eneida. 16ª ed. Madrid: Ed. Cátedra, 2016.
Los mejores hospitales privados de México. Revista Expansión. Enero de 2021.
Camus A. La peste. Penguin Random House. 1ª ed. México, 2020.
Sabato E. La resistencia. Barcelona: Ed. Seix Barral, 2003.
Full text